comparemela.com
Home
Live Updates
Biogen lifts profit view on heavy cost cuts, data on Alzheimers drug crucial : comparemela.com
Biogen lifts profit view on heavy cost cuts, data on Alzheimer's drug crucial
Biogen Inc on Tuesday said
the Alzheimer's disease drug it is developing with Japan's Eisai
Co Ltd would be used by doctors in a competitive market
as investors wait for data from rival therapies made... | October 25, 2022
Related Keywords
Bengaluru
,
Karnataka
,
India
,
Bhanvi Satija
,
Laura Chico
,
Manas Mishra
,
Michel Vounatsos
,
Arun Koyyur
,
Eisai Co Ltd
,
Drug Administration
,
Reuters
,
Biogen Inc On
,
Wall Street
,
Biogen Inc Stock Exchange
,
News
,
Information
,
Press Release
,
Biogen
,
Nc
,
N
,
Tuesday
,
Disease
,
Drug
,
It
,
Us
,
Developing
,
Ith
,
Td
,
Would
,
The
,
Ased
,
Y
,
Doctors
,
Ompetitive
,
Investors
,
Bait
,
Or
,
Data
,
Rom
,
Rival
,
Herapies Biib Us09062x1037
,
comparemela.com © 2020. All Rights Reserved.